McL-1 Stabilization Confers Resistance to Taxol in Human Gastric Cancer

Oncotarget - United States
doi 10.18632/oncotarget.20222
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Effects of Taxol Resistance Gene 1 on the Cisplatin Response in Gastric Cancer

Oncology Letters
Cancer ResearchOncology
2018English

McL-1 and BCL-xL Sequestration of Bak Confers Differential Resistance to BH3-only Proteins

Cell Death and Differentiation
Cell BiologyMolecular Biology
2018English

RNF138 Confers Cisplatin Resistance in Gastric Cancer Cells via Activating Chk1 Signaling Pathway

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

LMTK3 Confers Chemo-Resistance in Breast Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2018English

McL-1 Is a Relevant Molecular Target for Antisense Oligonucleotide Strategies in Gastric Cancer Cells

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2006English

miR-339-5p Downregulation Contributes to Taxol Resistance in Small-Cell Lung Cancer by Targeting Α1,2-Fucosyltransferase 1

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2017English

PC-1/PrLZ Confers Resistance to Rapamycin in Prostate Cancer Cells Through Increased 4e-Bp1 Stability

Oncotarget
Oncology
2015English

Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy